Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2696)
All Articles published online
|
May 21, 2008 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Stengel JZ, Arnold HL. Is infliximab safe to use while breastfeeding? World J Gastroenterol 2008; 14(19): 3085-3087 [PMID: 18494064 DOI: 10.3748/wjg.14.3085] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3214/full/v14/i19/3085.htm |
| Number | Citing Articles |
| 1 |
M. C. Soh, C. Nelson-Piercy. High-risk pregnancy and the rheumatologist. Rheumatology 2015; 54(4): 572 doi: 10.1093/rheumatology/keu394
|
| 2 |
Lucianna Motta Correia, Danielle Queiroz Bonilha, Juliana Dantas Ramos, Orlando Ambrogini, Sender Jankiel Miszputen. Treatment of inflammatory bowel disease and pregnancy: a review of the literature. Arquivos de Gastroenterologia 2010; 47(2): 197 doi: 10.1590/S0004-28032010000200016
|
| 3 |
Thomas W. Lee, Richard N. Fedorak. Tumor Necrosis Factor-α Monoclonal Antibodies in the Treatment of Inflammatory Bowel Disease: Clinical Practice Pharmacology. Gastroenterology Clinics of North America 2010; 39(3): 543 doi: 10.1016/j.gtc.2010.08.018
|
| 4 |
Casper Steenholdt, Magid Al-Khalaf, Mark A. Ainsworth, Jørn Brynskov. Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31. Journal of Crohn's and Colitis 2012; 6(3): 358 doi: 10.1016/j.crohns.2011.10.002
|
| 5 |
Bonnie L. Bermas. Lactation and Management of Postpartum Disease. Rheumatic Disease Clinics of North America 2017; 43(2): 249 doi: 10.1016/j.rdc.2016.12.002
|
| 6 |
Hagit Matz. Biologics in the Treatment of Skin Diseases During Pregnancy and Lactation. Current Dermatology Reports 2014; 3(3): 144 doi: 10.1007/s13671-014-0085-y
|
| 7 |
Anne Grosen, Mette Julsgaard, Jens Kelsen, Lisbet Ambrosius Christensen. Infliximab concentrations in the milk of nursing mothers with inflammatory bowel disease. Journal of Crohn's and Colitis 2014; 8(2): 175 doi: 10.1016/j.crohns.2013.09.003
|
| 8 |
Alfredo Papa, Giammarco Mocci, Michele Bonizzi, Carla Felice, Gianluca Andrisani, Italo De Vitis, Luisa Guidi, Antonio Gasbarrini. Use of Infliximab in Particular Clinical Settings: Management Based on Current Evidence. The American Journal of Gastroenterology 2009; 104(6): 1575 doi: 10.1038/ajg.2009.162
|
| 9 |
Harish Raja, Eric L Matteson, Clement J Michet, Justine R Smith, Jose S Pulido. Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding. Translational Vision Science & Technology 2012; 1(2): 6 doi: 10.1167/tvst.1.2.6
|
| 10 |
F. Bachmann, A. Nast, W. Sterry, S. Philipp. Safety and Efficacy of the Tumor Necrosis Factor Antagonists. Seminars in Cutaneous Medicine and Surgery 2010; 29(1): 35 doi: 10.1016/j.sder.2010.02.002
|
| 11 |
Lindsay A. Grotting, George N. Papaliodis. A Review of the Course and Treatment of Non-Infectious Uveitis during Pregnancy. Seminars in Ophthalmology 2017; 32(1): 75 doi: 10.1080/08820538.2016.1228402
|
| 12 |
Rebecca Matro, Christopher F. Martin, Douglas Wolf, Samir A. Shah, Uma Mahadevan. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development. Gastroenterology 2018; 155(3): 696 doi: 10.1053/j.gastro.2018.05.040
|
| 13 |
Ariella Bar-Gil Shitrit, Sorina Grisaru-Granovsky, Ami Ben Ya’acov, Eran Goldin. Management of Inflammatory Bowel Disease During Pregnancy. Digestive Diseases and Sciences 2016; 61(8): 2194 doi: 10.1007/s10620-016-4139-9
|
| 14 |
Z.Z.N. Yiu, C.E.M. Griffiths, R.B. Warren. Safety of biological therapies for psoriasis: effects on reproductive potential and outcomes in male and female patients. British Journal of Dermatology 2014; 171(3): 485 doi: 10.1111/bjd.13060
|
| 15 |
Bernadette Jenner, Catherine Nelson-Piercy. Respiratory Disease in Pregnancy. 2020; : 200 doi: 10.1017/9781108163705.022
|
| 16 |
Mehret Birru Talabi, Megan E.B. Clowse. Lahita's Systemic Lupus Erythematosus. 2021; : 389 doi: 10.1016/B978-0-12-820583-9.00045-2
|
| 17 |
Emma J Eshuis, Willem A Bemelman, Pieter CF Stokkers. Infliximab for the treatment of ulcerative colitis. Expert Review of Gastroenterology & Hepatology 2009; 3(3): 219 doi: 10.1586/egh.09.19
|
| 18 |
Nele Pentšuk, Jan Willem van der Laan. An interspecies comparison of placental antibody transfer: New insights into developmental toxicity testing of monoclonal antibodies. Birth Defects Research Part B: Developmental and Reproductive Toxicology 2009; 86(4): 328 doi: 10.1002/bdrb.20201
|
| 19 |
Pauline L. Martin, Clifford Sachs, Noritaka Imai, Hideshi Tsusaki, Satoru Oneda, Qun Jiao, George Treacy. Development in the cynomolgus macaque following administration of ustekinumab, a human anti‐il‐12/23p40 monoclonal antibody, during pregnancy and lactation. Birth Defects Research Part B: Developmental and Reproductive Toxicology 2010; 89(5): 351 doi: 10.1002/bdrb.20250
|
| 20 |
K. L. Hyrich, S. M. M. Verstappen. Biologic therapies and pregnancy: the story so far. Rheumatology 2014; 53(8): 1377 doi: 10.1093/rheumatology/ket409
|
| 21 |
Daniel C. Butler, Misha M. Heller, Jenny E. Murase. Safety of dermatologic medications in pregnancy and lactation. Journal of the American Academy of Dermatology 2014; 70(3): 417.e1 doi: 10.1016/j.jaad.2013.09.009
|
| 22 |
Paul Merlob, Corinna Weber-Schöndorfer. Drugs During Pregnancy and Lactation. 2015; : 775 doi: 10.1016/B978-0-12-408078-2.00035-4
|
| 23 |
Evelyne Vinet, Christian Pineau, Caroline Gordon, Ann E. Clarke, Sasha Bernatsky. Biologic therapy and pregnancy outcomes in women with rheumatic diseases. Arthritis Care & Research 2009; 61(5): 587 doi: 10.1002/art.24462
|
| 24 |
Maneesh Gogia, Daniel E. Furst. Rheumatoid arthritis and pregnancy: Disease activity, pregnancy outcomes, and treatment options during pregnancy and lactation. Drug Development Research 2011; 72(8): 689 doi: 10.1002/ddr.20478
|
| 25 |
Sara Horst, Sunanda Kane. The Use of Biologic Agents in Pregnancy and Breastfeeding. Gastroenterology Clinics of North America 2014; 43(3): 495 doi: 10.1016/j.gtc.2014.05.005
|
| 26 |
Sumona Saha, Nancy Reau. Yamada' s Textbook of Gastroenterology. 2015; : 834 doi: 10.1002/9781118512074.ch46
|
| 27 |
Catalin S. Buhimschi, Carl P. Weiner. High Risk Pregnancy. 2011; : 579 doi: 10.1016/B978-1-4160-5908-0.00034-X
|
| 28 |
Javier P Gisbert, María Chaparro. Vaccines in Children Exposed to Biological AgentsIn Uteroand/or During Breastfeeding: Are They Effective and Safe?. Journal of Crohn's and Colitis 2023; 17(6): 995 doi: 10.1093/ecco-jcc/jjad005
|
| 29 |
Frank Hoentjen, Ad A van Bodegraven. Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease. World Journal of Gastroenterology 2009; 15(17): 2067-2073 doi: 10.3748/wjg.15.2067
|
| 30 |
Vivian Wai-Mei Huang, Hsiu-Ju Chang, Karen Ivy Kroeker, Karen Jean Goodman, Kathleen M. Hegadoren, Levinus Albert Dieleman, Richard Neil Fedorak. Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding Varies Widely: A Need for Further Education. Canadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/6193275
|
| 31 |
K Mitchell, M Kaul, MEB Clowse. The management of rheumatic diseases in pregnancy. Scandinavian Journal of Rheumatology 2010; 39(2): 99 doi: 10.3109/03009740903449313
|
| 32 |
Séverine Vermeire, Franck Carbonnel, Pierre G. Coulie, Vincent Geenen, Johanna M.W. Hazes, Pierre L. Masson, Filip De Keyser, Edouard Louis. Management of inflammatory bowel disease in pregnancy. Journal of Crohn's and Colitis 2012; 6(8): 811 doi: 10.1016/j.crohns.2012.04.009
|
| 33 |
F. M. Habal, V. W. Huang. Review article: a decision‐making algorithm for the management of pregnancy in the inflammatory bowel disease patient. Alimentary Pharmacology & Therapeutics 2012; 35(5): 501 doi: 10.1111/j.1365-2036.2011.04967.x
|
| 34 |
José Luis Cabriada, Isabel Vera, Eugeni Domènech, Manuel Barreiro-de Acosta, María Esteve, Javier P. Gisbert, Julia Panés, Fernando Gomollón. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre el uso de fármacos antifactor de necrosis tumoral α en la enfermedad inflamatoria intestinal (2013). Gastroenterología y Hepatología 2013; 36(3): 127 doi: 10.1016/j.gastrohep.2013.01.002
|
| 35 |
Monika Østensen. Management of early aggressive rheumatoid arthritis during pregnancy and lactation. Expert Opinion on Pharmacotherapy 2009; 10(9): 1469 doi: 10.1517/14656560902980194
|
| 36 |
|
| 37 |
C. Janneke van der Woude, Sanja Kolacek, Iris Dotan, Tom Øresland, Séverine Vermeire, Pia Munkholm, Uma Mahadevan, Lucy Mackillop, Axel Dignass. European evidenced-based consensus on reproduction in inflammatory bowel disease. Journal of Crohn's and Colitis 2010; 4(5): 493 doi: 10.1016/j.crohns.2010.07.004
|
| 38 |
Jeffrey W. Molloy, Joel Z. Stengel, Hays L. Arnold. Infliximab: A Review of its Use in the Treatment of Crohn's Disease. Clinical Medicine. Therapeutics 2009; 1: CMT.S2250 doi: 10.4137/CMT.S2250
|
| 39 |
Juejing Ling, Gideon Koren. Challenges in vaccinating infants born to mothers taking immunoglobulin biologicals during pregnancy. Expert Review of Vaccines 2016; 15(2): 239 doi: 10.1586/14760584.2016.1115351
|
| 40 |
Megan EB Clowse, Frauke Förger, Caroline Hwang, John Thorp, Radboud JEM Dolhain, Astrid van Tubergen, Laura Shaughnessy, Jeff Simpson, Marie Teil, Nathalie Toublanc, Maggie Wang, Thomas W Hale. Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study. Annals of the Rheumatic Diseases 2017; 76(11): 1890 doi: 10.1136/annrheumdis-2017-211384
|
| 41 |
Dana C Moffatt, Alexandra Ilnyckyj, Charles N Bernstein. A Population-Based Study of Breastfeeding in Inflammatory Bowel Disease: Initiation, Duration, and Effect on Disease in the Postpartum Period. The American Journal of Gastroenterology 2009; 104(10): 2517 doi: 10.1038/ajg.2009.362
|
| 42 |
Shomron Ben–Horin, Miri Yavzori, Lior Katz, Orit Picard, Ella Fudim, Yehuda Chowers, Alon Lang. Adalimumab Level in Breast Milk of a Nursing Mother. Clinical Gastroenterology and Hepatology 2010; 8(5): 475 doi: 10.1016/j.cgh.2009.11.023
|
| 43 |
British Association of Dermatologists' Management Guidelines. 2011; : 205 doi: 10.1002/9781444329865.ch4
|
| 44 |
Marcus Martineau, Dorian O Haskard, Catherine Nelson-Piercy. Behçet's syndrome in pregnancy. Obstetric Medicine 2010; 3(1): 2 doi: 10.1258/om.2009.090033
|
| 45 |
David James, Philip J. Steer, Carl P. Weiner, Bernard Gonik, Stephen C, Robson. High-Risk Pregnancy. 2018; doi: 10.1017/9781108349185
|
| 46 |
|
| 47 |
Ole Haagen Nielsen, Edward V Loftus Jr, Tine Jess. Safety of TNF-α inhibitors during IBD pregnancy: a systematic review. BMC Medicine 2013; 11(1) doi: 10.1186/1741-7015-11-174
|
| 48 |
S. Smitha Prabhu, Punya Suvarna. Biological agents in pregnancy and lactation – A rational approach. Journal of Skin and Sexually Transmitted Diseases 2019; 1: 54 doi: 10.25259/JSSTD_19_2019
|
| 49 |
Javier P Gisbert, María Chaparro. Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease. American Journal of Gastroenterology 2013; 108(9): 1426 doi: 10.1038/ajg.2013.171
|
| 50 |
Pauline L. Martin, Gerhard F. Weinbauer. Developmental Toxicity Testing of Biopharmaceuticals in Nonhuman Primates. International Journal of Toxicology 2010; 29(6): 552 doi: 10.1177/1091581810378896
|
| 51 |
C.H. Smith, A.V. Anstey, J.N.W.N. Barker, A.D. Burden, R.J.G. Chalmers, D.A. Chandler, A.Y. Finlay, C.E.M. Griffiths, K. Jackson, N.J. McHugh, K.E. McKenna, N.J. Reynolds, A.D. Ormerod. British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009. British Journal of Dermatology 2009; 161(5): 987 doi: 10.1111/j.1365-2133.2009.09505.x
|
| 52 |
W. Miehsler, G. Novacek, H. Wenzl, H. Vogelsang, P. Knoflach, A. Kaser, C. Dejaco, W. Petritsch, M. Kapitan, H. Maier, W. Graninger, H. Tilg, W. Reinisch. A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease. Journal of Crohn's and Colitis 2010; 4(3): 221 doi: 10.1016/j.crohns.2009.12.001
|
| 53 |
Jill K. J. Gaidos, Sunanda V. Kane. Treatment of Inflammatory Bowel Disease with Biologics. 2018; : 81 doi: 10.1007/978-3-319-60276-9_6
|
| 54 |
Sara C. LaHue, Annika Anderson, Kristen M. Krysko, Alice Rutatangwa, Morna J. Dorsey, Thomas Hale, Uma Mahadevan, Elizabeth E. Rogers, Melissa G. Rosenstein, Riley Bove. Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases. Neurology Neuroimmunology & Neuroinflammation 2020; 7(4) doi: 10.1212/NXI.0000000000000769
|
| 55 |
Geoffrey C. Nguyen, Cynthia H. Seow, Cynthia Maxwell, Vivian Huang, Yvette Leung, Jennifer Jones, Grigorios I. Leontiadis, Frances Tse, Uma Mahadevan, C. Janneke van der Woude, Alain Bitton, Brian Bressler, Sharyle Fowler, John K. Marshall, Carrie Palatnick, Anna Pupco, Joel Ray, Laura Targownik, Janneke van der Woude, William Paterson. The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Gastroenterology 2016; 150(3): 734 doi: 10.1053/j.gastro.2015.12.003
|
| 56 |
Lai Shan Tam, James Cheng‐Chung Wei, Amita Aggarwal, Han Joo Baek, Peter P. Cheung, Praveena Chiowchanwisawakit, Leonila Dans, Jieruo Gu, Noboru Hagino, Mitsumasa Kishimoto, Heizel Manapat Reyes, Soosan Soroosh, Simon Stebbings, Samuel Whittle, Swan Sim Yeap, Chak Sing Lau. 2018 APLAR axial spondyloarthritis treatment recommendations. International Journal of Rheumatic Diseases 2019; 22(3): 340 doi: 10.1111/1756-185X.13510
|
| 57 |
Patricia Shu Kurizky, Clarissa de Castro Ferreira, Lucas Souza Carmo Nogueira, Licia Maria Henrique da Mota. Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding. Anais Brasileiros de Dermatologia 2015; 90(3): 367 doi: 10.1590/abd1806-4841.20153113
|
| 58 |
Javier P. Gisbert. Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding. Inflammatory Bowel Diseases 2010; 16(5): 881 doi: 10.1002/ibd.21154
|
| 59 |
Marcelo Arnone, Maria Denise Fonseca Takahashi, André Vicente Esteves de Carvalho, Wanderley Marques Bernardo, Aline Lopes Bressan, Andrea Machado Coelho Ramos, Aripuanã Cobério Terena, Cacilda da Silva Souza, Daniel Holthausen Nunes, Maria Cecília de Carvalho Bortoletto, Maria de Fátima Santos Paim de Oliveira, Jane Marcy Neffá, Luciana Cristina Fieri, Luna Azulay-Abulafia, Paulo Antônio Oldani Felix, Renata Ferreira Magalhaes, Ricardo Romiti, Tatiana Jerez Jaime. Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology. Anais Brasileiros de Dermatologia 2019; 94(2 suppl 1): 76 doi: 10.1590/abd1806-4841.2019940211
|
| 60 |
Maria Soledad Ormaechea, Muhammad Hassan, Neil Onghanseng, Jung Hyun Park, Sarakshi Mahajan, Khalid Yusuf Al-Kirwi, Gunay Uludag, Muhammad Sohail Halim, Ariel Schlaen, Yasir J Sepah, Diana V Do, Quan Dong Nguyen. Safety of systemic therapy for noninfectious uveitis. Expert Opinion on Drug Safety 2019; 18(12): 1219 doi: 10.1080/14740338.2019.1692810
|
| 61 |
Xinaida T. Lima, Elizabeth M. Seidler, Hermênio C. Lima, Alexandra B. Kimball. Long-term safety of biologics in dermatology. Dermatologic Therapy 2009; 22(1): 2 doi: 10.1111/j.1529-8019.2008.01212.x
|
| 62 |
Kei Takayama, Sho Ishikawa, Toshio Enoki, Teruo Kojima, Masaru Takeuchi. Successful Treatment with Infliximab for Behçet Disease during Pregnancy. Ocular Immunology and Inflammation 2013; 21(4): 321 doi: 10.3109/09273948.2013.781655
|
| 63 |
Nabeel Khan, Hamna Asim, Gary R Lichtenstein. Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy. Expert Opinion on Drug Safety 2014; 13(12): 1699 doi: 10.1517/14740338.2014.973399
|
| 64 |
|
| 65 |
Miguel Cordero-Coma, Raquel Salazar-Méndez, Taygan Yilmaz. Treatment of severe non-infectious uveitis in high-risk conditions (Part I): pregnancy and malignancies, management and safety issues. Expert Opinion on Drug Safety 2015; 14(7): 1071 doi: 10.1517/14740338.2015.1044969
|
| 66 |
Manuela Marzo, Carla Felice, Gian Lodovico Rapaccini, Luisa Guidi, Alessandro Armuzzi. Infliximab: A Review of Its Use in the Treatment of Inflammatory Bowel Disease. Clinical Medicine Insights: Therapeutics 2011; 3: CMT.S1978 doi: 10.4137/CMT.S1978
|
| 67 |
Ernst Beinder, Thorsten Fischer, Dieter Grab, Thomas Grubert, Peer Hantschmann, Franz Kainer, Ralph Kästner, Christina Kentenich, Walter Klockenbusch, Reinhard Kopp, Frank Lammert, Frank Louwen, Ioannis Mylonas, Stephanie Pildner von Steinburg, Werner Rath, Ute M. Schäfer-Graf, Ekkehard Schleußner, Ralf Schmitz, Maximilian Sohn, Heinrich Otto Steitz. Facharzt Geburtsmedizin. 2012; : 369 doi: 10.1016/B978-3-437-23751-5.10017-2
|
| 68 |
Shiu-chung Au, Ari Goldminz, Manasa Bhandarkar, Alice Gottlieb. Safety Updates on Tumor Necrosis Factor Blockers. Psoriasis Forum 2012; (3): 98 doi: 10.1177/247553031218a00301
|
| 69 |
María Chaparro, Javier P Gisbert. How safe is infliximab therapy during pregnancy and lactation in inflammatory bowel disease?. Expert Opinion on Drug Safety 2014; 13(12): 1749 doi: 10.1517/14740338.2014.959489
|
| 70 |
Tamara Lund, Simon Francis Thomsen. Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series. Dermatologic Therapy 2017; 30(3): e12454 doi: 10.1111/dth.12454
|
| 71 |
Shomron Ben-Horin, Miri Yavzori, Uri Kopylov, Orit Picard, Ella Fudim, Rami Eliakim, Yehuda Chowers, Alon Lang. Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease. Journal of Crohn's and Colitis 2011; 5(6): 555 doi: 10.1016/j.crohns.2011.05.006
|
| 72 |
Zaid Shihab, Neville D. Yeomans, Peter De Cruz. Anti-Tumour Necrosis Factor α Therapies and Inflammatory Bowel Disease Pregnancy Outcomes: A Meta-analysis. Journal of Crohn's and Colitis 2016; 10(8): 979 doi: 10.1093/ecco-jcc/jjv234
|
| 73 |
Nabeel Khan, Hamna Asim, Gary R Lichtenstein. Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy. Expert Opinion on Drug Safety 2014; : 1 doi: 10.1517/14740338.2015.973399
|